Trial Outcomes & Findings for MRI for Non-invasive Evaluation of Brain Stress (NCT NCT01898650)
NCT ID: NCT01898650
Last Updated: 2023-05-23
Results Overview
To be measured with both oxygen extraction fraction and arterial spin labeling to measure blood flow.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
12 participants
Primary outcome timeframe
during the single MRI scan, approximately 30 - 45 minutes
Results posted on
2023-05-23
Participant Flow
Patients were recruited from the beginning of 2013 (anticipated date) until September 2014 (anticipated date).
Participant milestones
| Measure |
Craniofacial Abnormalities
Subjects with craniosynostosis or other craniofacial abnormalities associated with ICP who will undergo an MR scan.
MR scan
|
|---|---|
|
Overall Study
STARTED
|
12
|
|
Overall Study
Scanned
|
11
|
|
Overall Study
COMPLETED
|
11
|
|
Overall Study
NOT COMPLETED
|
1
|
Reasons for withdrawal
| Measure |
Craniofacial Abnormalities
Subjects with craniosynostosis or other craniofacial abnormalities associated with ICP who will undergo an MR scan.
MR scan
|
|---|---|
|
Overall Study
the subject would not lie still for imaging
|
1
|
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Craniofacial Abnormalities
n=12 Participants
Subjects with craniosynostosis or other craniofacial abnormalities associated with ICP who will undergo an MR scan.
MR scan
|
|---|---|
|
Age, Categorical
<=18 years
|
12 Participants
n=12 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=12 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=12 Participants
|
|
Sex: Female, Male
Female
|
4 Participants
n=12 Participants
|
|
Sex: Female, Male
Male
|
8 Participants
n=12 Participants
|
|
Region of Enrollment
United States
|
12 Participants
n=12 Participants
|
PRIMARY outcome
Timeframe: during the single MRI scan, approximately 30 - 45 minutesTo be measured with both oxygen extraction fraction and arterial spin labeling to measure blood flow.
Outcome measures
| Measure |
Craniofacial Abnormalities
n=6 Participants
Subjects with craniosynostosis or other craniofacial abnormalities associated with ICP who will undergo an MR scan.
MR scan
|
|---|---|
|
Blood Flow and Perfusion
|
26.8 ml/min/100g
Standard Deviation 5.6
|
Adverse Events
Craniofacial Abnormalities
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place